Metraipolis › archive › dc_a60d07243e87

Adverse events of androgen receptor pathway inhibitors in prostate cancer from real world data — Europe PMC PMID:41134826

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41134826
DOI
10.1371/journal.pone.0335459
License (as archived)
solo-consultazione
Archived
2026-11-09T02:14:10.419Z
SHA-256 of the archived text
7f1f79d17949bb009518dab6fa1e27266c0c2ccf1bd1365fe9f28c2c64f27b06
Stable URL of this page
https://metraipolis.com/documento/dc_a60d07243e87

How to cite

Adverse events of androgen receptor pathway inhibitors in prostate cancer from real world data — Europe PMC PMID:41134826 — Europe PMC (en), https://europepmc.org/article/MED/41134826 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a60d07243e87 (Metraipolis archive dc_a60d07243e87, sha256 7f1f79d17949bb009518dab6fa1e27266c0c2ccf1bd1365fe9f28c2c64f27b06)
BibTeX
@misc{dca60d07243e87,
  title = {Adverse events of androgen receptor pathway inhibitors in prostate cancer from real world data — Europe PMC PMID:41134826},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41134826},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a60d07243e87; sha256 7f1f79d17949bb009518dab6fa1e27266c0c2ccf1bd1365fe9f28c2c64f27b06},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41134826. Agents can read the archived copy with the MCP tool read_document.